Novartis (ADR) (NVS)

Novartis has climbed roughly 7% above its recent trend, its fastest run in a while.

What is going on right now?

The price has risen quickly over the past few weeks, with more shares changing hands than usual. Streaks like this have often taken a breather.

How is the business itself doing?

Novartis makes medicines, and it keeps about 23 cents of every dollar it earns as profit. Sales grew only slightly, and earnings actually dropped by about a sixth compared to last year.

What stands out?

The company pays out roughly 72% of its earnings to shareholders, while its debts are a bit larger than its total ownership value. That combination leaves less room if earnings keep shrinking.

What comes next?

Novartis reports its next quarterly results on October 27, the first look at whether that earnings dip is reversing.